UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
FORM 8-K
CURRENT REPORT
Pursuant To Section
13 or 15(d) of the Securities Exchange Act of 1934
Date of report:
November 30, 2006
Date of earliest event reported: November 30, 2006
PFIZER
INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
1-3619
(Commission File Number)
13-5315170
(I.R.S. Employer Identification No.)
235
East 42nd Street, New York, New York 10017
(Address of principal executive
offices) (zip code)
(212) 573-2323
(Registrant's telephone number)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the obligation of the registrant under any
of the following provisions:
[ ] Written communication pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01. Other
Events
Exhibit 100 to this Current
Report on Form 8-K contains documents formatted in XBRL (eXtensible Business
Reporting Language) with information from Pfizer Inc.'s Quarterly Report on
Form 10-Q for the quarter ended July 2,
2006, filed with the Securities and
Exchange Commission (SEC) on August 11,
2006. The information formatted in XBRL
includes the (i) Condensed Consolidated Statements of Income for the three and
six months ended July 2, 2006 and July 3, 2005, (ii) Condensed Consolidated
Balance Sheets at July 2, 2006 and December 31, 2005, and (iii) Condensed
Consolidated Statements of Cash Flows for the six months ended July 2, 2006 and
July 3, 2005.
Users of this data are
advised pursuant to Rule 401 of Regulation S-T that the financial information
contained in the XBRL-Related Documents is unaudited and these are not the official
financial statements of Pfizer Inc. as filed with the SEC. The purpose of
furnishing these XBRL formatted documents is solely for the purpose of participation
in the SEC's voluntary XBRL pilot program to test the related format and
technology and, as a result, investors should continue to rely on the official
filed version of the furnished documents and not rely on the information in
this Current Report on Form 8-K, including Exhibit 100, in making investment
decisions.
In accordance with Rule
402 of Regulation S-T, the information in this Current Report on Form 8-K,
including Exhibit 100, shall not be deemed to be "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liability of that section, and shall
not be incorporated by reference into any registration statement or other
document filed under the Securities Act of 1933, as amended, or the Exchange
Act, except as shall be expressly set forth by specific reference in such
filing.
Item 9.01. Financial
Statements and Exhibits.
(d)
Exhibits
The following exhibits are
furnished herewith:
Exhibit Number
Exhibit Description
100
The following financial
statements from Pfizer Inc.'s Quarterly Report on Form 10-Q for the quarter
ended July 2, 2006, filed on August 11, 2006, formatted in XBRL (eXtensible
Business Reporting Language): (i) the Condensed Consolidated Statements of Income
for the three and six months ended July 2, 2006 and July 3, 2005, (ii) the
Condensed Consolidated Balance Sheets at July 2, 2006 and December 31, 2005,
and (iii) the Condensed Consolidated Statements of Cash Flows for the six
months ended July 2, 2006 and July 3, 2005.
SIGNATURE
Under the requirements of the
Securities Exchange Act of 1934, the registrant has caused this report to be
signed on its behalf by the authorized undersigned.
PFIZER INC.
By:
/s/ Margaret M. Foran
Margaret M. Foran
Dated: November 30, 2006
Title: Senior Vice
President-Corporate Governance
Associate General Counsel and Corporate Secretary
EXHIBIT INDEX
Exhibit No.
Description
EX-100.INS
XBRL Instance Document
EX-100.SCH
XBRL Taxonomy Extension
Schema Document
EX-100.SCH.1
XBRL Schema Supplement Document
EX-100.CAL
XBRL Taxonomy Extension
Calculation Linkbase Document
EX-100.LAB
XBRL Taxonomy Extension
Label Linkbase Document
EX-100.PRE
XBRL Taxonomy Extension
Presentation Linkbase Document